A
Athena P. Kourtis
Researcher at Centers for Disease Control and Prevention
Publications - 244
Citations - 7965
Athena P. Kourtis is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Pregnancy. The author has an hindex of 39, co-authored 227 publications receiving 6781 citations. Previous affiliations of Athena P. Kourtis include University of North Carolina at Chapel Hill & Eastern Virginia Medical School.
Papers
More filters
Journal ArticleDOI
Pregnancy and Infection
TL;DR: This review includes an update on immunologic alterations during pregnancy, and an increased severity of infections with some organisms, including influenza virus, hepatitis E virus, herpes simplex virus, and malaria parasites.
Journal ArticleDOI
Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
Charles Chasela,Michael G. Hudgens,Denise J. Jamieson,Dumbani Kayira,Mina C. Hosseinipour,Athena P. Kourtis,Francis Martinson,Gerald Tegha,Rodney J. Knight,Yusuf Ahmed,Deborah Kamwendo,Irving F. Hoffman,Sascha R. Ellington,Zebrone Kacheche,Alice Soko,Jeffrey Wiener,Susan A. Fiscus,Peter N. Kazembe,Innocent Mofolo,Maggie Chigwenembe,Dorothy Sichali,Charles van der Horst +21 more
TL;DR: The use of either a maternal antiretroviral regimen or infant nevirapine for 28 weeks was effective in reducing HIV-1 transmission during breast-feeding.
Journal ArticleDOI
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
Athena P. Kourtis,Kelly M Hatfield,James Baggs,Mu Y,Isaac See,Erin Epson,Joelle Nadle,Marion A. Kainer,Ghinwa Dumyati,Sue Petit,Susan M. Ray,Ham D,Capers C,Ewing H,Nicole Coffin,L. C. McDonald,John A. Jernigan,Denise M. Cardo +17 more
TL;DR: To reduce the incidence of S. aureus bloodstream infections in the United States, health care facilities should take steps to fully implement CDC recommendations for prevention of device- and procedure-associated infections and for interruption of transmission.
Journal ArticleDOI
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
TL;DR: Evidence indicates that antiretroviral therapy during pregnancy is not associated with an overall increased risk of premature delivery, and the use of combination regimens before or early in pregnancy may slightly increase the risk of prematurity.
Journal ArticleDOI
Diabetes Trends Among Delivery Hospitalizations in the U.S., 1994–2004
Sandra S. Albrecht,Elena V. Kuklina,Pooja Bansil,Denise J. Jamieson,Maura K. Whiteman,Athena P. Kourtis,Samuel F. Posner,William M. Callaghan +7 more
TL;DR: Given the increasing prevalence of diabetes among delivery hospitalizations, particularly among younger women, it will be important to monitor trends in the pregnant population and target strategies to minimize risk for maternal/fetal complications.